SUBSEQUENT EVENTS

3 Months Ended

Mar. 31, 2019

Subsequent Events [Abstract]

SUBSEQUENT EVENTS

14. SUBSEQUENT EVENTS

The Company has evaluated events and transactions that occurred from March 31, 2019 through the date of the filing for possible disclosure and recognition in the financial statements.

On April 4, 2019, the company borrowed $50,000 from a related party. The Note bears interest at 10% and is due in twelve months.

On April 12, 2019, the Company borrowed $289,144 from a related party to continue its clinical trials in the U.S. The Note bears interest at 10% and is due in twelve months.